FDA Adverse Event Injury Summary report: N

ENDOTAK RELIANCE

MDR report key: 3053253 · Received April 11, 2013

Report

Report Number
2124215-2013-04931
Event Type
Injury
Date Received
April 11, 2013
Date of Event
March 19, 2013
Report Date
March 19, 2013
Manufacturer
CPI - DEL CARIBE
Product Code
NVY
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

ACCORDING TO AVAILABLE INFORMATION, THIS LEAD REMAINS IMPLANTED AND IN SERVICE. AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS RIGHT VENTRICULAR LEAD PLAYED A HIGH OUT OF RANGE SHOCK IMPEDANCE MEASUREMENT. A REVIEW OF THE DATA REVEALED VARIABLE SHOCK IMPEDANCE MEASUREMENTS DURING THE PAST YEAR AND ONLY ONE OUT OF RANGE MEASUREMENT. IN ADDITION, WHEN THE LEAD WAS IMPLANTED IN 2007, NORMAL SENSING MEASUREMENTS OFF >6 MV WERE OBTAINED. SENSING DECREASED TO 2.9 TO 3.8 MV. DURING AN INTENDED DEVICE REPLACEMENT PROCEDURE, A DECISION WAS MADE TO LEAVE THIS LEAD IMPLANTED AND FURTHER MONITOR. MOVEMENT AFTER SURGERY DID NOT REVEAL NOISE. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
154618 ENDOTAK RELIANCE IMPLANTABLE LEAD NVY CPI - DEL CARIBE 0181

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| L